Germany is the bigger Anti-Depressants Drugs market: $659 Mn against $468 Mn in 2023, about 1.4 times as large.
Germany grows faster: 0.9% a year, against 0.7%.
Clinical research: 61 active trials in the UK, 56 in Germany.
| Measure |  UK |  Germany |
|---|---|---|
| Market size, 2023 | $468 Mn | $659 Mn |
| Market size, 2033 projected | $502 Mn | $721 Mn |
| Growth a year (CAGR) | 0.7% | 0.9% |
| Money added, 2023–2033 | $34 Mn | $62 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $6.74 | $7.90 |
| Active clinical trials | 61 | 56 |
| Full report | UK report | Germany report |
Year by year, 2023 to 2033
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Anti-Depressants Drugs, UK or Germany?
Germany is the bigger Anti-Depressants Drugs market: $659 Mn against $468 Mn in 2023, about 1.4 times as large.
Which grows faster in Anti-Depressants Drugs, UK or Germany?
Germany grows faster: 0.9% a year, against 0.7%.
More Anti-Depressants Drugs comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.